BDB564765
BD Pharmingen™ Purified NA/LE Human BD Fc Block™
Manufacturer: BD
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | BDB564765-Each-of-1 | In Stock | ₹ 37,475.28 |
BDB564765 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 37,475.28
GST (18%): ₹ 6,745.55
Total Price: ₹ 44,220.83
Quantity
0.25 mg
Formulation
No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001ng/μg) of protein as determined by the LAL assay.
Concentration
1.0 mg/mL
Content And Storage
Store undiluted at 4°C
Related Products
Description
- Fcγ Receptors belong to the immunoglobulin superfamily and are expressed at varying levels in multiple cell lineages including high expression in myeloid and B cells
- The major functions of Fc receptors are protective functions of the immune system
- There are multiple different types of Fc receptors reflecting a variety of different biological activities, which are modulated when they are aggregated by multivalent antigen-antibody complexes
- While normally serving important physiological roles in the immune system, Fc Receptors can also be the cause of nonspecific, false-positive antibody staining of cells
- Human BD Fc Block™ is designed and formulated to block or significantly reduce potential non-specific antibody staining caused by receptors for IgG that may be encountered in various applications including the flow cytometric analysis of human cells
- Moreover, it can increase the specificity of antibody labeling of extremely rare target cells such as antigen-specific B cells, fetal cells in maternal blood, hematopoietic progenitor cells, or disseminated epithelial tumor cells
- Order Info This preparation contains no preservatives, thus it should be handled under aseptic conditions.
Compare Similar Items
Show Difference
Quantity: 0.25 mg
Formulation: No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001ng/μg) of protein as determined by the LAL assay.
Concentration: 1.0 mg/mL
Content And Storage: Store undiluted at 4°C
Quantity:
0.25 mg
Formulation:
No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001ng/μg) of protein as determined by the LAL assay.
Concentration:
1.0 mg/mL
Content And Storage:
Store undiluted at 4°C
Quantity: 0.1 mg
Formulation: Aqueous buffered solution containing ≤0.09% sodium azide.
Concentration: 0.5mg/mL
Content And Storage: Store undiluted at 4°C
Quantity:
0.1 mg
Formulation:
Aqueous buffered solution containing ≤0.09% sodium azide.
Concentration:
0.5mg/mL
Content And Storage:
Store undiluted at 4°C
Quantity: 50 Tests
Formulation: Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Concentration: __
Content And Storage: Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Quantity:
50 Tests
Formulation:
Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Concentration:
__
Content And Storage:
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Quantity: 25 μg
Formulation: Aqueous buffered solution containing ≤0.09% sodium azide
Concentration: 0.2mg/mL
Content And Storage: Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Quantity:
25 μg
Formulation:
Aqueous buffered solution containing ≤0.09% sodium azide
Concentration:
0.2mg/mL
Content And Storage:
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.